Clinical Trial Results:
A multi-centre, double-blind, placebo-controlled, randomised, parallel group
clinical trial to evaluate efficacy and safety of Actovegin® in diabetic type 2
patients with symptomatic diabetic peripheral polyneuropathy
Summary
|
|
EudraCT number |
2006-004007-19 |
Trial protocol |
AT |
Global completion date |
01 Mar 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Apr 2016
|
First version publication date |
07 Apr 2016
|
Other versions |
|
Summary report(s) |
Results Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.